Supplements During Cancer: Help or Hype?
September 14, 2011 – Laura Beil
Unlocking the Mystery of Cancer Stem Cells
September 14, 2011 – Elaine Schattner, MD
Advocates Make Cancer Their Mission
September 14, 2011 – Marc Silver
Choosing an Imaging Test
September 14, 2011 – Charlotte Huff
Do You Need a Cancer Coach?
September 14, 2011 – Jennifer M. Gangloff
Coordinating Care After Cancer
September 14, 2011 – Dawn Dorsey
How to Manage Family Dynamics During Cancer
September 14, 2011 – Jane Hill
Currently Viewing
Another State Gets Chemo Parity
September 14, 2011 – Taylor Walker
Breast Cancer Drug Scores Win in Prevention
September 14, 2011 – Elizabeth Whittington
Critical Care: A New Nurse Faces Death, Life, and Everything in Between
September 14, 2011 – Kathy LaTour
A Survivorship Resource Map
September 14, 2011 – Elizabeth Whittington
Q & A: Patients Want Coordinated Care
September 14, 2011 – Len Lichtenfeld, MD
San Antonio Breast Cancer Symposium
September 14, 2011 – Lindsay Ray
The Meaning of Stem Cells
September 14, 2011 – Debu Tripathy, MD
Comments from Readers
September 14, 2011
Managing Cancer-Related Diarrhea
September 14, 2011 – Katy Human
Supplement Research in Cancer Lacking
September 14, 2011 – Barrie Cassileth, PhD
Pipeline
September 14, 2011 – Lindsay Ray
Remaining Faithful
September 14, 2011 – Cheryl L. Rice
Açaí Berry’s Effect on Cancer in Question
September 14, 2011 – Jason Roberson
What Caused Your Cancer?
September 14, 2011 – Staff Reports
Searching for a Cancer Coach?
September 14, 2011 – Jennifer M. Gangloff
Tell What You’re Taking
September 14, 2011 – Laura Beil
Don’t Believe Everything You Read on Supplement Labels
September 14, 2011 – Laura Beil
Understanding Clinical Trials
September 14, 2011
Checking Out a Charity
September 14, 2011 – Marc Silver
Should You “Just Do It?”
September 14, 2011 – Marc Silver
Previvors Need Expert Guidance, Close Surveillance
September 14, 2011 – Dawn Dorsey
Safety in Numbers
September 14, 2011 – Jane Hill
Flaxseed Doesn't Help With Hot Flashes
September 14, 2011 – Kathy LaTour
From Our Archives: Imaging
September 16, 2011
From Our Archives: Supplements
September 14, 2011
Vitamin D and Folate May Reduce Colon Cancer Risk
September 14, 2011 – Lena Huang
Sleep Problems Impair Childhood Cancer Survivors
September 14, 2011 – Taylor Walker
Cancer Imaging Gets Sophisticated
September 14, 2011 – Susan R. Peck, PhD
From Our Archives: Advocacy
September 14, 2011

Another State Gets Chemo Parity

Texas joins nine other states in requiring health insurance providers to cover oral chemo the same as I.V. treatments.

BY Taylor Walker
PUBLISHED September 14, 2011

In May, Texas Governor Rick Perry signed legislation that requires health insurance providers to cover orally administered chemotherapy drugs in the same manner as intravenous cancer treatments. Nine other states and the District of Columbia have currently passed chemotherapy parity laws. Similar bills have been introduced in approximately 20 other states.

The Texas law has the potential to drastically reduce the economic burden placed upon a growing number of cancer patients who rely on inadequate healthcare plans to purchase their costly oral medications.  

With oncology drug prices continuously escalating (rising 11.5 percent in 2010, according to the Medco 2011 Drug Trend Report), patients who can’t manage these high costs are left with few options. Some abandon medication altogether, especially in cases where there is no intravenous substitute. 

A reason for this disparity is intravenous and oral cancer medications are typically filed under different benefit plans. Insurance policies typically cover most, if not all, costs related to intravenously administered chemotherapy. However, oral versions of the same drug are classified as prescription drugs, which requires the patient to pay a much larger copayment, or share of the cost, according to an April 2010 Office of Legislative Research report.

Both forms of chemotherapy have existed for decades, but oral medications have recently increased in number and indications for usage. In addition to the 40 oral chemotherapy drugs already approved by the Food and Drug Administration, 25 percent of the estimated 400 chemotherapy drugs under development are expected to be created in oral form, according to an August 2010 study by the Texas Department of Insurance. The problem is, only about 28 percent of these oral drugs have intravenous alternatives, forcing many patients to either pay the additional cost of oral medications or go without.

Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.

Related Articles

1
×

Sign In

Not a member? Sign up now!
×

Sign Up

Are you a member? Please Log In